Dx Revision Watch
Senior Member (Voting Rights)
I'm posting this 2016 letter from Prof Crawley, on behalf of the MAGENTA team, to the REC, as some may not have previously seen it in earlier threads:
https://dxrevisionwatch.files.wordpress.com/2024/03/ethics-letter-31.10.16.pdf
Centre for Child & Adolescent Health
Oakfield House
Clifton BS8 2BN
Tel: 0117 331 4085
http://www.bristol.ac.uk/ccah/
Dear Natasha
RE: 15 SW 0124. The MAGENTA Trial
Thank you for offering me, on behalf of the MAGENTA team, the opportunity to address these concerns. I have addressed each issue in turn and I have also enclosed copies of the relevant publications.
The REC is probably aware that there are always campaigns against CFS/ME research, particularly research into behavioural approaches to treatment. These have been well described in both the scientific and lay press and are alluded to by the complainant. The current campaigns are focussed on treatment trials but also extend into biological research. There is currently a campaign against the MAGENTA trial and I have therefore provided a summary (appendix 1) of what has happened to date with this campaign.
My patients and participants in MAGENTA want research and want access to the full range of treatment options. This is reflected in the consistently high recruitment and retention rates we have experienced with MAGENTA. As you know, we included integrated qualitative studies in MAGENTA and we asked participants and their parents about both the trial and their views on graded exercise therapy (GET). Patients and participants like GET and want to be able to have it. They also want more research and want to be involved in trials...
Full letter addressing a number of complaints from an unidentified complainant here:
https://dxrevisionwatch.files.wordpress.com/2024/03/ethics-letter-31.10.16.pdf
I'm sorry I don't have time to go through it and quote important responses Crawley had made to the REC in response to the complaints.
ETA: "appendix 1" - is not included in the PDF.
https://dxrevisionwatch.files.wordpress.com/2024/03/ethics-letter-31.10.16.pdf
Centre for Child & Adolescent Health
Oakfield House
Clifton BS8 2BN
Tel: 0117 331 4085
http://www.bristol.ac.uk/ccah/
Dear Natasha
RE: 15 SW 0124. The MAGENTA Trial
Thank you for offering me, on behalf of the MAGENTA team, the opportunity to address these concerns. I have addressed each issue in turn and I have also enclosed copies of the relevant publications.
The REC is probably aware that there are always campaigns against CFS/ME research, particularly research into behavioural approaches to treatment. These have been well described in both the scientific and lay press and are alluded to by the complainant. The current campaigns are focussed on treatment trials but also extend into biological research. There is currently a campaign against the MAGENTA trial and I have therefore provided a summary (appendix 1) of what has happened to date with this campaign.
My patients and participants in MAGENTA want research and want access to the full range of treatment options. This is reflected in the consistently high recruitment and retention rates we have experienced with MAGENTA. As you know, we included integrated qualitative studies in MAGENTA and we asked participants and their parents about both the trial and their views on graded exercise therapy (GET). Patients and participants like GET and want to be able to have it. They also want more research and want to be involved in trials...
Full letter addressing a number of complaints from an unidentified complainant here:
https://dxrevisionwatch.files.wordpress.com/2024/03/ethics-letter-31.10.16.pdf
I'm sorry I don't have time to go through it and quote important responses Crawley had made to the REC in response to the complaints.
ETA: "appendix 1" - is not included in the PDF.
Last edited: